nodes	percent_of_prediction	percent_of_DWPC	metapath
Saquinavir—ABCC1—Epirubicin—urinary bladder cancer	0.0473	0.0721	CbGbCtD
Saquinavir—ABCB1—Mitomycin—urinary bladder cancer	0.0433	0.0659	CbGbCtD
Saquinavir—ABCC1—Etoposide—urinary bladder cancer	0.0368	0.0562	CbGbCtD
Saquinavir—ABCC2—Carboplatin—urinary bladder cancer	0.0325	0.0495	CbGbCtD
Saquinavir—ABCG2—Fluorouracil—urinary bladder cancer	0.0295	0.045	CbGbCtD
Saquinavir—ABCG2—Carboplatin—urinary bladder cancer	0.0294	0.0448	CbGbCtD
Saquinavir—ABCC2—Cisplatin—urinary bladder cancer	0.0278	0.0423	CbGbCtD
Saquinavir—ABCC2—Etoposide—urinary bladder cancer	0.0273	0.0416	CbGbCtD
Saquinavir—ABCC1—Doxorubicin—urinary bladder cancer	0.0251	0.0383	CbGbCtD
Saquinavir—ABCG2—Cisplatin—urinary bladder cancer	0.0251	0.0382	CbGbCtD
Saquinavir—ABCG2—Etoposide—urinary bladder cancer	0.0247	0.0376	CbGbCtD
Saquinavir—ABCC1—Methotrexate—urinary bladder cancer	0.0243	0.0371	CbGbCtD
Saquinavir—SLCO1A2—Methotrexate—urinary bladder cancer	0.0217	0.0331	CbGbCtD
Saquinavir—SLCO1B1—Methotrexate—urinary bladder cancer	0.0205	0.0313	CbGbCtD
Saquinavir—ALB—Fluorouracil—urinary bladder cancer	0.0204	0.031	CbGbCtD
Saquinavir—CYP3A4—Thiotepa—urinary bladder cancer	0.0196	0.0299	CbGbCtD
Saquinavir—ABCC2—Doxorubicin—urinary bladder cancer	0.0186	0.0283	CbGbCtD
Saquinavir—ABCC2—Methotrexate—urinary bladder cancer	0.018	0.0275	CbGbCtD
Saquinavir—ABCG2—Doxorubicin—urinary bladder cancer	0.0168	0.0256	CbGbCtD
Saquinavir—ABCG2—Methotrexate—urinary bladder cancer	0.0163	0.0248	CbGbCtD
Saquinavir—CYP2C8—Fluorouracil—urinary bladder cancer	0.0157	0.024	CbGbCtD
Saquinavir—CYP3A5—Etoposide—urinary bladder cancer	0.0137	0.0208	CbGbCtD
Saquinavir—CYP2C8—Etoposide—urinary bladder cancer	0.0131	0.02	CbGbCtD
Saquinavir—ABCB1—Gemcitabine—urinary bladder cancer	0.0125	0.019	CbGbCtD
Saquinavir—ALB—Methotrexate—urinary bladder cancer	0.0112	0.0171	CbGbCtD
Saquinavir—CYP2C9—Fluorouracil—urinary bladder cancer	0.011	0.0167	CbGbCtD
Saquinavir—CYP2C9—Cisplatin—urinary bladder cancer	0.00932	0.0142	CbGbCtD
Saquinavir—ABCB1—Cisplatin—urinary bladder cancer	0.00905	0.0138	CbGbCtD
Saquinavir—ABCB1—Etoposide—urinary bladder cancer	0.00889	0.0135	CbGbCtD
Saquinavir—ABCB1—Doxorubicin—urinary bladder cancer	0.00606	0.00924	CbGbCtD
Saquinavir—ABCB1—Methotrexate—urinary bladder cancer	0.00587	0.00895	CbGbCtD
Saquinavir—CYP2D6—Doxorubicin—urinary bladder cancer	0.00571	0.00871	CbGbCtD
Saquinavir—CYP3A4—Etoposide—urinary bladder cancer	0.00533	0.00812	CbGbCtD
Saquinavir—CYP3A4—Doxorubicin—urinary bladder cancer	0.00363	0.00554	CbGbCtD
Saquinavir—Mitiglinide—UGT2B7—urinary bladder cancer	0.00331	0.719	CrCbGaD
Saquinavir—CYP2C19—urine—urinary bladder cancer	0.00269	0.0816	CbGeAlD
Saquinavir—CYP2C9—urine—urinary bladder cancer	0.00209	0.0633	CbGeAlD
Saquinavir—CYP3A4—urine—urinary bladder cancer	0.00159	0.0483	CbGeAlD
Saquinavir—CYP2D6—urine—urinary bladder cancer	0.00156	0.0475	CbGeAlD
Saquinavir—ORM1—prostate gland—urinary bladder cancer	0.00137	0.0415	CbGeAlD
Saquinavir—Mitiglinide—PPARG—urinary bladder cancer	0.00129	0.281	CrCbGaD
Saquinavir—ABCC2—prostate gland—urinary bladder cancer	0.00112	0.0341	CbGeAlD
Saquinavir—SLCO1B1—renal system—urinary bladder cancer	0.00101	0.0307	CbGeAlD
Saquinavir—ABCC1—prostate gland—urinary bladder cancer	0.00099	0.03	CbGeAlD
Saquinavir—CYP11A1—female reproductive system—urinary bladder cancer	0.000989	0.03	CbGeAlD
Saquinavir—SLC22A1—renal system—urinary bladder cancer	0.000854	0.0259	CbGeAlD
Saquinavir—ABCC1—seminal vesicle—urinary bladder cancer	0.000837	0.0254	CbGeAlD
Saquinavir—SLCO1A2—renal system—urinary bladder cancer	0.000822	0.025	CbGeAlD
Saquinavir—ABCG2—prostate gland—urinary bladder cancer	0.000819	0.0249	CbGeAlD
Saquinavir—SLCO1B1—female reproductive system—urinary bladder cancer	0.000809	0.0246	CbGeAlD
Saquinavir—ABCC2—renal system—urinary bladder cancer	0.000766	0.0232	CbGeAlD
Saquinavir—CYP3A5—prostate gland—urinary bladder cancer	0.000761	0.0231	CbGeAlD
Saquinavir—ORM1—female reproductive system—urinary bladder cancer	0.000747	0.0227	CbGeAlD
Saquinavir—ABCG2—seminal vesicle—urinary bladder cancer	0.000693	0.021	CbGeAlD
Saquinavir—ABCC1—urethra—urinary bladder cancer	0.000663	0.0201	CbGeAlD
Saquinavir—SLC22A1—vagina—urinary bladder cancer	0.000618	0.0188	CbGeAlD
Saquinavir—ABCC2—female reproductive system—urinary bladder cancer	0.000613	0.0186	CbGeAlD
Saquinavir—CYP11A1—lymph node—urinary bladder cancer	0.000579	0.0176	CbGeAlD
Saquinavir—CYP2C8—renal system—urinary bladder cancer	0.000574	0.0174	CbGeAlD
Saquinavir—ABCG2—urethra—urinary bladder cancer	0.000549	0.0167	CbGeAlD
Saquinavir—CYP3A5—renal system—urinary bladder cancer	0.000518	0.0157	CbGeAlD
Saquinavir—ABCC1—vagina—urinary bladder cancer	0.000489	0.0148	CbGeAlD
Saquinavir—CYP2C19—vagina—urinary bladder cancer	0.000477	0.0145	CbGeAlD
Saquinavir—CYP2C8—female reproductive system—urinary bladder cancer	0.00046	0.014	CbGeAlD
Saquinavir—ORM1—lymph node—urinary bladder cancer	0.000437	0.0133	CbGeAlD
Saquinavir—CYP2C8—vagina—urinary bladder cancer	0.000416	0.0126	CbGeAlD
Saquinavir—CYP2C9—female reproductive system—urinary bladder cancer	0.000409	0.0124	CbGeAlD
Saquinavir—ABCG2—vagina—urinary bladder cancer	0.000405	0.0123	CbGeAlD
Saquinavir—ABCB1—prostate gland—urinary bladder cancer	0.000404	0.0123	CbGeAlD
Saquinavir—CYP3A4—renal system—urinary bladder cancer	0.000389	0.0118	CbGeAlD
Saquinavir—ALB—lymph node—urinary bladder cancer	0.000383	0.0116	CbGeAlD
Saquinavir—CYP2D6—renal system—urinary bladder cancer	0.000383	0.0116	CbGeAlD
Saquinavir—CYP3A5—vagina—urinary bladder cancer	0.000376	0.0114	CbGeAlD
Saquinavir—ABCC2—lymph node—urinary bladder cancer	0.000359	0.0109	CbGeAlD
Saquinavir—ABCB1—seminal vesicle—urinary bladder cancer	0.000342	0.0104	CbGeAlD
Saquinavir—ABCC1—lymph node—urinary bladder cancer	0.000316	0.00959	CbGeAlD
Saquinavir—CYP3A4—female reproductive system—urinary bladder cancer	0.000312	0.00946	CbGeAlD
Saquinavir—CYP2D6—female reproductive system—urinary bladder cancer	0.000307	0.00931	CbGeAlD
Saquinavir—ABCB1—epithelium—urinary bladder cancer	0.000297	0.00901	CbGeAlD
Saquinavir—ABCB1—renal system—urinary bladder cancer	0.000275	0.00836	CbGeAlD
Saquinavir—ABCB1—urethra—urinary bladder cancer	0.000271	0.00821	CbGeAlD
Saquinavir—ABCG2—lymph node—urinary bladder cancer	0.000262	0.00794	CbGeAlD
Saquinavir—ABCB1—female reproductive system—urinary bladder cancer	0.000221	0.00669	CbGeAlD
Saquinavir—ABCB1—vagina—urinary bladder cancer	0.000199	0.00605	CbGeAlD
Saquinavir—ABCB1—lymph node—urinary bladder cancer	0.000129	0.00392	CbGeAlD
Saquinavir—Body temperature increased—Etoposide—urinary bladder cancer	8.47e-05	0.000394	CcSEcCtD
Saquinavir—Urinary tract infection—Doxorubicin—urinary bladder cancer	8.47e-05	0.000394	CcSEcCtD
Saquinavir—Conjunctivitis—Doxorubicin—urinary bladder cancer	8.47e-05	0.000394	CcSEcCtD
Saquinavir—Haemorrhage—Epirubicin—urinary bladder cancer	8.45e-05	0.000393	CcSEcCtD
Saquinavir—Hepatitis—Epirubicin—urinary bladder cancer	8.45e-05	0.000393	CcSEcCtD
Saquinavir—Eye disorder—Methotrexate—urinary bladder cancer	8.44e-05	0.000392	CcSEcCtD
Saquinavir—Diarrhoea—Fluorouracil—urinary bladder cancer	8.44e-05	0.000392	CcSEcCtD
Saquinavir—Tinnitus—Methotrexate—urinary bladder cancer	8.42e-05	0.000392	CcSEcCtD
Saquinavir—Hypoaesthesia—Epirubicin—urinary bladder cancer	8.41e-05	0.000391	CcSEcCtD
Saquinavir—Asthenia—Cisplatin—urinary bladder cancer	8.39e-05	0.00039	CcSEcCtD
Saquinavir—Pharyngitis—Epirubicin—urinary bladder cancer	8.39e-05	0.00039	CcSEcCtD
Saquinavir—Cardiac disorder—Methotrexate—urinary bladder cancer	8.38e-05	0.00039	CcSEcCtD
Saquinavir—Urinary tract disorder—Epirubicin—urinary bladder cancer	8.35e-05	0.000388	CcSEcCtD
Saquinavir—Connective tissue disorder—Epirubicin—urinary bladder cancer	8.3e-05	0.000386	CcSEcCtD
Saquinavir—Urethral disorder—Epirubicin—urinary bladder cancer	8.28e-05	0.000385	CcSEcCtD
Saquinavir—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	8.24e-05	0.000383	CcSEcCtD
Saquinavir—Epistaxis—Doxorubicin—urinary bladder cancer	8.22e-05	0.000382	CcSEcCtD
Saquinavir—Angiopathy—Methotrexate—urinary bladder cancer	8.19e-05	0.000381	CcSEcCtD
Saquinavir—Sinusitis—Doxorubicin—urinary bladder cancer	8.17e-05	0.00038	CcSEcCtD
Saquinavir—Immune system disorder—Methotrexate—urinary bladder cancer	8.16e-05	0.000379	CcSEcCtD
Saquinavir—Dizziness—Fluorouracil—urinary bladder cancer	8.16e-05	0.000379	CcSEcCtD
Saquinavir—Visual impairment—Epirubicin—urinary bladder cancer	8.14e-05	0.000379	CcSEcCtD
Saquinavir—Mediastinal disorder—Methotrexate—urinary bladder cancer	8.14e-05	0.000378	CcSEcCtD
Saquinavir—Chills—Methotrexate—urinary bladder cancer	8.1e-05	0.000377	CcSEcCtD
Saquinavir—Diarrhoea—Cisplatin—urinary bladder cancer	8e-05	0.000372	CcSEcCtD
Saquinavir—Erythema multiforme—Epirubicin—urinary bladder cancer	7.99e-05	0.000372	CcSEcCtD
Saquinavir—Alopecia—Methotrexate—urinary bladder cancer	7.98e-05	0.000371	CcSEcCtD
Saquinavir—Vomiting—Gemcitabine—urinary bladder cancer	7.98e-05	0.000371	CcSEcCtD
Saquinavir—Mental disorder—Methotrexate—urinary bladder cancer	7.91e-05	0.000368	CcSEcCtD
Saquinavir—Rash—Gemcitabine—urinary bladder cancer	7.91e-05	0.000368	CcSEcCtD
Saquinavir—Dermatitis—Gemcitabine—urinary bladder cancer	7.9e-05	0.000367	CcSEcCtD
Saquinavir—Eye disorder—Epirubicin—urinary bladder cancer	7.9e-05	0.000367	CcSEcCtD
Saquinavir—Hypersensitivity—Etoposide—urinary bladder cancer	7.89e-05	0.000367	CcSEcCtD
Saquinavir—Tinnitus—Epirubicin—urinary bladder cancer	7.88e-05	0.000366	CcSEcCtD
Saquinavir—Erythema—Methotrexate—urinary bladder cancer	7.86e-05	0.000366	CcSEcCtD
Saquinavir—Malnutrition—Methotrexate—urinary bladder cancer	7.86e-05	0.000366	CcSEcCtD
Saquinavir—Haemoglobin—Doxorubicin—urinary bladder cancer	7.86e-05	0.000365	CcSEcCtD
Saquinavir—Headache—Gemcitabine—urinary bladder cancer	7.86e-05	0.000365	CcSEcCtD
Saquinavir—Cardiac disorder—Epirubicin—urinary bladder cancer	7.84e-05	0.000365	CcSEcCtD
Saquinavir—Vomiting—Fluorouracil—urinary bladder cancer	7.84e-05	0.000365	CcSEcCtD
Saquinavir—Rhinitis—Doxorubicin—urinary bladder cancer	7.84e-05	0.000365	CcSEcCtD
Saquinavir—Haemorrhage—Doxorubicin—urinary bladder cancer	7.82e-05	0.000364	CcSEcCtD
Saquinavir—Hepatitis—Doxorubicin—urinary bladder cancer	7.82e-05	0.000364	CcSEcCtD
Saquinavir—Hypoaesthesia—Doxorubicin—urinary bladder cancer	7.78e-05	0.000362	CcSEcCtD
Saquinavir—Rash—Fluorouracil—urinary bladder cancer	7.78e-05	0.000362	CcSEcCtD
Saquinavir—Dermatitis—Fluorouracil—urinary bladder cancer	7.77e-05	0.000361	CcSEcCtD
Saquinavir—Pharyngitis—Doxorubicin—urinary bladder cancer	7.76e-05	0.000361	CcSEcCtD
Saquinavir—Headache—Fluorouracil—urinary bladder cancer	7.73e-05	0.000359	CcSEcCtD
Saquinavir—Urinary tract disorder—Doxorubicin—urinary bladder cancer	7.72e-05	0.000359	CcSEcCtD
Saquinavir—Dysgeusia—Methotrexate—urinary bladder cancer	7.7e-05	0.000358	CcSEcCtD
Saquinavir—Asthenia—Etoposide—urinary bladder cancer	7.68e-05	0.000357	CcSEcCtD
Saquinavir—Connective tissue disorder—Doxorubicin—urinary bladder cancer	7.68e-05	0.000357	CcSEcCtD
Saquinavir—Angiopathy—Epirubicin—urinary bladder cancer	7.67e-05	0.000357	CcSEcCtD
Saquinavir—Urethral disorder—Doxorubicin—urinary bladder cancer	7.66e-05	0.000356	CcSEcCtD
Saquinavir—Immune system disorder—Epirubicin—urinary bladder cancer	7.63e-05	0.000355	CcSEcCtD
Saquinavir—Mediastinal disorder—Epirubicin—urinary bladder cancer	7.62e-05	0.000354	CcSEcCtD
Saquinavir—Back pain—Methotrexate—urinary bladder cancer	7.6e-05	0.000354	CcSEcCtD
Saquinavir—Chills—Epirubicin—urinary bladder cancer	7.58e-05	0.000353	CcSEcCtD
Saquinavir—Pruritus—Etoposide—urinary bladder cancer	7.58e-05	0.000352	CcSEcCtD
Saquinavir—Visual impairment—Doxorubicin—urinary bladder cancer	7.54e-05	0.00035	CcSEcCtD
Saquinavir—Alopecia—Epirubicin—urinary bladder cancer	7.47e-05	0.000347	CcSEcCtD
Saquinavir—Nausea—Gemcitabine—urinary bladder cancer	7.45e-05	0.000347	CcSEcCtD
Saquinavir—Vomiting—Cisplatin—urinary bladder cancer	7.43e-05	0.000346	CcSEcCtD
Saquinavir—Mental disorder—Epirubicin—urinary bladder cancer	7.4e-05	0.000344	CcSEcCtD
Saquinavir—Erythema multiforme—Doxorubicin—urinary bladder cancer	7.39e-05	0.000344	CcSEcCtD
Saquinavir—Rash—Cisplatin—urinary bladder cancer	7.37e-05	0.000343	CcSEcCtD
Saquinavir—Dermatitis—Cisplatin—urinary bladder cancer	7.36e-05	0.000343	CcSEcCtD
Saquinavir—Erythema—Epirubicin—urinary bladder cancer	7.36e-05	0.000342	CcSEcCtD
Saquinavir—Malnutrition—Epirubicin—urinary bladder cancer	7.36e-05	0.000342	CcSEcCtD
Saquinavir—Diarrhoea—Etoposide—urinary bladder cancer	7.33e-05	0.000341	CcSEcCtD
Saquinavir—Nausea—Fluorouracil—urinary bladder cancer	7.33e-05	0.000341	CcSEcCtD
Saquinavir—Eye disorder—Doxorubicin—urinary bladder cancer	7.31e-05	0.00034	CcSEcCtD
Saquinavir—Ill-defined disorder—Methotrexate—urinary bladder cancer	7.29e-05	0.000339	CcSEcCtD
Saquinavir—Tinnitus—Doxorubicin—urinary bladder cancer	7.29e-05	0.000339	CcSEcCtD
Saquinavir—Anaemia—Methotrexate—urinary bladder cancer	7.27e-05	0.000338	CcSEcCtD
Saquinavir—Cardiac disorder—Doxorubicin—urinary bladder cancer	7.26e-05	0.000337	CcSEcCtD
Saquinavir—Flatulence—Epirubicin—urinary bladder cancer	7.25e-05	0.000337	CcSEcCtD
Saquinavir—Dysgeusia—Epirubicin—urinary bladder cancer	7.2e-05	0.000335	CcSEcCtD
Saquinavir—Back pain—Epirubicin—urinary bladder cancer	7.12e-05	0.000331	CcSEcCtD
Saquinavir—Angiopathy—Doxorubicin—urinary bladder cancer	7.09e-05	0.00033	CcSEcCtD
Saquinavir—Malaise—Methotrexate—urinary bladder cancer	7.09e-05	0.00033	CcSEcCtD
Saquinavir—Dizziness—Etoposide—urinary bladder cancer	7.08e-05	0.000329	CcSEcCtD
Saquinavir—Muscle spasms—Epirubicin—urinary bladder cancer	7.07e-05	0.000329	CcSEcCtD
Saquinavir—Immune system disorder—Doxorubicin—urinary bladder cancer	7.06e-05	0.000328	CcSEcCtD
Saquinavir—Vertigo—Methotrexate—urinary bladder cancer	7.06e-05	0.000328	CcSEcCtD
Saquinavir—Mediastinal disorder—Doxorubicin—urinary bladder cancer	7.05e-05	0.000328	CcSEcCtD
Saquinavir—Leukopenia—Methotrexate—urinary bladder cancer	7.04e-05	0.000327	CcSEcCtD
Saquinavir—Chills—Doxorubicin—urinary bladder cancer	7.02e-05	0.000326	CcSEcCtD
Saquinavir—Nausea—Cisplatin—urinary bladder cancer	6.94e-05	0.000323	CcSEcCtD
Saquinavir—Alopecia—Doxorubicin—urinary bladder cancer	6.91e-05	0.000321	CcSEcCtD
Saquinavir—Cough—Methotrexate—urinary bladder cancer	6.86e-05	0.000319	CcSEcCtD
Saquinavir—Mental disorder—Doxorubicin—urinary bladder cancer	6.85e-05	0.000319	CcSEcCtD
Saquinavir—Ill-defined disorder—Epirubicin—urinary bladder cancer	6.83e-05	0.000317	CcSEcCtD
Saquinavir—Convulsion—Methotrexate—urinary bladder cancer	6.81e-05	0.000317	CcSEcCtD
Saquinavir—Vomiting—Etoposide—urinary bladder cancer	6.81e-05	0.000317	CcSEcCtD
Saquinavir—Erythema—Doxorubicin—urinary bladder cancer	6.81e-05	0.000317	CcSEcCtD
Saquinavir—Malnutrition—Doxorubicin—urinary bladder cancer	6.81e-05	0.000317	CcSEcCtD
Saquinavir—Anaemia—Epirubicin—urinary bladder cancer	6.8e-05	0.000316	CcSEcCtD
Saquinavir—Agitation—Epirubicin—urinary bladder cancer	6.76e-05	0.000314	CcSEcCtD
Saquinavir—Rash—Etoposide—urinary bladder cancer	6.75e-05	0.000314	CcSEcCtD
Saquinavir—Dermatitis—Etoposide—urinary bladder cancer	6.75e-05	0.000314	CcSEcCtD
Saquinavir—Headache—Etoposide—urinary bladder cancer	6.71e-05	0.000312	CcSEcCtD
Saquinavir—Flatulence—Doxorubicin—urinary bladder cancer	6.71e-05	0.000312	CcSEcCtD
Saquinavir—Arthralgia—Methotrexate—urinary bladder cancer	6.69e-05	0.000311	CcSEcCtD
Saquinavir—Chest pain—Methotrexate—urinary bladder cancer	6.69e-05	0.000311	CcSEcCtD
Saquinavir—Myalgia—Methotrexate—urinary bladder cancer	6.69e-05	0.000311	CcSEcCtD
Saquinavir—Dysgeusia—Doxorubicin—urinary bladder cancer	6.67e-05	0.00031	CcSEcCtD
Saquinavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	6.65e-05	0.000309	CcSEcCtD
Saquinavir—Malaise—Epirubicin—urinary bladder cancer	6.63e-05	0.000309	CcSEcCtD
Saquinavir—Discomfort—Methotrexate—urinary bladder cancer	6.61e-05	0.000308	CcSEcCtD
Saquinavir—Vertigo—Epirubicin—urinary bladder cancer	6.61e-05	0.000307	CcSEcCtD
Saquinavir—Syncope—Epirubicin—urinary bladder cancer	6.6e-05	0.000307	CcSEcCtD
Saquinavir—Leukopenia—Epirubicin—urinary bladder cancer	6.59e-05	0.000306	CcSEcCtD
Saquinavir—Back pain—Doxorubicin—urinary bladder cancer	6.58e-05	0.000306	CcSEcCtD
Saquinavir—Muscle spasms—Doxorubicin—urinary bladder cancer	6.54e-05	0.000304	CcSEcCtD
Saquinavir—Confusional state—Methotrexate—urinary bladder cancer	6.47e-05	0.000301	CcSEcCtD
Saquinavir—Loss of consciousness—Epirubicin—urinary bladder cancer	6.47e-05	0.000301	CcSEcCtD
Saquinavir—Cough—Epirubicin—urinary bladder cancer	6.42e-05	0.000299	CcSEcCtD
Saquinavir—Convulsion—Epirubicin—urinary bladder cancer	6.37e-05	0.000296	CcSEcCtD
Saquinavir—Infection—Methotrexate—urinary bladder cancer	6.37e-05	0.000296	CcSEcCtD
Saquinavir—Nausea—Etoposide—urinary bladder cancer	6.36e-05	0.000296	CcSEcCtD
Saquinavir—Hypertension—Epirubicin—urinary bladder cancer	6.35e-05	0.000295	CcSEcCtD
Saquinavir—Ill-defined disorder—Doxorubicin—urinary bladder cancer	6.32e-05	0.000294	CcSEcCtD
Saquinavir—Nervous system disorder—Methotrexate—urinary bladder cancer	6.29e-05	0.000293	CcSEcCtD
Saquinavir—Anaemia—Doxorubicin—urinary bladder cancer	6.29e-05	0.000293	CcSEcCtD
Saquinavir—Thrombocytopenia—Methotrexate—urinary bladder cancer	6.28e-05	0.000292	CcSEcCtD
Saquinavir—Chest pain—Epirubicin—urinary bladder cancer	6.26e-05	0.000291	CcSEcCtD
Saquinavir—Myalgia—Epirubicin—urinary bladder cancer	6.26e-05	0.000291	CcSEcCtD
Saquinavir—Arthralgia—Epirubicin—urinary bladder cancer	6.26e-05	0.000291	CcSEcCtD
Saquinavir—Agitation—Doxorubicin—urinary bladder cancer	6.26e-05	0.000291	CcSEcCtD
Saquinavir—Anxiety—Epirubicin—urinary bladder cancer	6.24e-05	0.00029	CcSEcCtD
Saquinavir—Skin disorder—Methotrexate—urinary bladder cancer	6.23e-05	0.00029	CcSEcCtD
Saquinavir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	6.22e-05	0.000289	CcSEcCtD
Saquinavir—Hyperhidrosis—Methotrexate—urinary bladder cancer	6.2e-05	0.000288	CcSEcCtD
Saquinavir—Discomfort—Epirubicin—urinary bladder cancer	6.19e-05	0.000288	CcSEcCtD
Saquinavir—Malaise—Doxorubicin—urinary bladder cancer	6.14e-05	0.000285	CcSEcCtD
Saquinavir—Dry mouth—Epirubicin—urinary bladder cancer	6.13e-05	0.000285	CcSEcCtD
Saquinavir—Vertigo—Doxorubicin—urinary bladder cancer	6.12e-05	0.000284	CcSEcCtD
Saquinavir—Anorexia—Methotrexate—urinary bladder cancer	6.12e-05	0.000284	CcSEcCtD
Saquinavir—Syncope—Doxorubicin—urinary bladder cancer	6.1e-05	0.000284	CcSEcCtD
Saquinavir—Leukopenia—Doxorubicin—urinary bladder cancer	6.09e-05	0.000283	CcSEcCtD
Saquinavir—Confusional state—Epirubicin—urinary bladder cancer	6.05e-05	0.000282	CcSEcCtD
Saquinavir—Oedema—Epirubicin—urinary bladder cancer	6e-05	0.000279	CcSEcCtD
Saquinavir—Hypotension—Methotrexate—urinary bladder cancer	5.99e-05	0.000279	CcSEcCtD
Saquinavir—Loss of consciousness—Doxorubicin—urinary bladder cancer	5.98e-05	0.000278	CcSEcCtD
Saquinavir—Infection—Epirubicin—urinary bladder cancer	5.96e-05	0.000277	CcSEcCtD
Saquinavir—Cough—Doxorubicin—urinary bladder cancer	5.94e-05	0.000276	CcSEcCtD
Saquinavir—Shock—Epirubicin—urinary bladder cancer	5.91e-05	0.000275	CcSEcCtD
Saquinavir—Convulsion—Doxorubicin—urinary bladder cancer	5.9e-05	0.000274	CcSEcCtD
Saquinavir—Nervous system disorder—Epirubicin—urinary bladder cancer	5.89e-05	0.000274	CcSEcCtD
Saquinavir—Thrombocytopenia—Epirubicin—urinary bladder cancer	5.88e-05	0.000273	CcSEcCtD
Saquinavir—Hypertension—Doxorubicin—urinary bladder cancer	5.88e-05	0.000273	CcSEcCtD
Saquinavir—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	5.85e-05	0.000272	CcSEcCtD
Saquinavir—Skin disorder—Epirubicin—urinary bladder cancer	5.83e-05	0.000271	CcSEcCtD
Saquinavir—Hyperhidrosis—Epirubicin—urinary bladder cancer	5.8e-05	0.00027	CcSEcCtD
Saquinavir—Insomnia—Methotrexate—urinary bladder cancer	5.8e-05	0.00027	CcSEcCtD
Saquinavir—Myalgia—Doxorubicin—urinary bladder cancer	5.8e-05	0.00027	CcSEcCtD
Saquinavir—Chest pain—Doxorubicin—urinary bladder cancer	5.8e-05	0.00027	CcSEcCtD
Saquinavir—Arthralgia—Doxorubicin—urinary bladder cancer	5.8e-05	0.00027	CcSEcCtD
Saquinavir—Anxiety—Doxorubicin—urinary bladder cancer	5.78e-05	0.000269	CcSEcCtD
Saquinavir—Paraesthesia—Methotrexate—urinary bladder cancer	5.76e-05	0.000268	CcSEcCtD
Saquinavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	5.76e-05	0.000268	CcSEcCtD
Saquinavir—Discomfort—Doxorubicin—urinary bladder cancer	5.73e-05	0.000266	CcSEcCtD
Saquinavir—Anorexia—Epirubicin—urinary bladder cancer	5.72e-05	0.000266	CcSEcCtD
Saquinavir—Dyspnoea—Methotrexate—urinary bladder cancer	5.72e-05	0.000266	CcSEcCtD
Saquinavir—Somnolence—Methotrexate—urinary bladder cancer	5.7e-05	0.000265	CcSEcCtD
Saquinavir—Dry mouth—Doxorubicin—urinary bladder cancer	5.67e-05	0.000264	CcSEcCtD
Saquinavir—Dyspepsia—Methotrexate—urinary bladder cancer	5.65e-05	0.000263	CcSEcCtD
Saquinavir—Hypotension—Epirubicin—urinary bladder cancer	5.61e-05	0.000261	CcSEcCtD
Saquinavir—Confusional state—Doxorubicin—urinary bladder cancer	5.6e-05	0.000261	CcSEcCtD
Saquinavir—Decreased appetite—Methotrexate—urinary bladder cancer	5.58e-05	0.000259	CcSEcCtD
Saquinavir—Oedema—Doxorubicin—urinary bladder cancer	5.56e-05	0.000258	CcSEcCtD
Saquinavir—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	5.54e-05	0.000258	CcSEcCtD
Saquinavir—Fatigue—Methotrexate—urinary bladder cancer	5.53e-05	0.000257	CcSEcCtD
Saquinavir—Infection—Doxorubicin—urinary bladder cancer	5.52e-05	0.000257	CcSEcCtD
Saquinavir—Pain—Methotrexate—urinary bladder cancer	5.49e-05	0.000255	CcSEcCtD
Saquinavir—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	5.47e-05	0.000254	CcSEcCtD
Saquinavir—Shock—Doxorubicin—urinary bladder cancer	5.47e-05	0.000254	CcSEcCtD
Saquinavir—Nervous system disorder—Doxorubicin—urinary bladder cancer	5.45e-05	0.000253	CcSEcCtD
Saquinavir—Thrombocytopenia—Doxorubicin—urinary bladder cancer	5.44e-05	0.000253	CcSEcCtD
Saquinavir—Insomnia—Epirubicin—urinary bladder cancer	5.43e-05	0.000253	CcSEcCtD
Saquinavir—Skin disorder—Doxorubicin—urinary bladder cancer	5.4e-05	0.000251	CcSEcCtD
Saquinavir—Paraesthesia—Epirubicin—urinary bladder cancer	5.39e-05	0.000251	CcSEcCtD
Saquinavir—Hyperhidrosis—Doxorubicin—urinary bladder cancer	5.37e-05	0.00025	CcSEcCtD
Saquinavir—Dyspnoea—Epirubicin—urinary bladder cancer	5.35e-05	0.000249	CcSEcCtD
Saquinavir—Somnolence—Epirubicin—urinary bladder cancer	5.34e-05	0.000248	CcSEcCtD
Saquinavir—Anorexia—Doxorubicin—urinary bladder cancer	5.3e-05	0.000246	CcSEcCtD
Saquinavir—Feeling abnormal—Methotrexate—urinary bladder cancer	5.29e-05	0.000246	CcSEcCtD
Saquinavir—Dyspepsia—Epirubicin—urinary bladder cancer	5.29e-05	0.000246	CcSEcCtD
Saquinavir—Gastrointestinal pain—Methotrexate—urinary bladder cancer	5.25e-05	0.000244	CcSEcCtD
Saquinavir—Decreased appetite—Epirubicin—urinary bladder cancer	5.22e-05	0.000243	CcSEcCtD
Saquinavir—Hypotension—Doxorubicin—urinary bladder cancer	5.19e-05	0.000241	CcSEcCtD
Saquinavir—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	5.18e-05	0.000241	CcSEcCtD
Saquinavir—Fatigue—Epirubicin—urinary bladder cancer	5.18e-05	0.000241	CcSEcCtD
Saquinavir—Pain—Epirubicin—urinary bladder cancer	5.13e-05	0.000239	CcSEcCtD
Saquinavir—Constipation—Epirubicin—urinary bladder cancer	5.13e-05	0.000239	CcSEcCtD
Saquinavir—Urticaria—Methotrexate—urinary bladder cancer	5.1e-05	0.000237	CcSEcCtD
Saquinavir—Abdominal pain—Methotrexate—urinary bladder cancer	5.07e-05	0.000236	CcSEcCtD
Saquinavir—Body temperature increased—Methotrexate—urinary bladder cancer	5.07e-05	0.000236	CcSEcCtD
Saquinavir—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	5.06e-05	0.000235	CcSEcCtD
Saquinavir—Insomnia—Doxorubicin—urinary bladder cancer	5.02e-05	0.000234	CcSEcCtD
Saquinavir—Paraesthesia—Doxorubicin—urinary bladder cancer	4.99e-05	0.000232	CcSEcCtD
Saquinavir—Dyspnoea—Doxorubicin—urinary bladder cancer	4.95e-05	0.00023	CcSEcCtD
Saquinavir—Feeling abnormal—Epirubicin—urinary bladder cancer	4.95e-05	0.00023	CcSEcCtD
Saquinavir—Somnolence—Doxorubicin—urinary bladder cancer	4.94e-05	0.00023	CcSEcCtD
Saquinavir—Gastrointestinal pain—Epirubicin—urinary bladder cancer	4.91e-05	0.000228	CcSEcCtD
Saquinavir—Dyspepsia—Doxorubicin—urinary bladder cancer	4.89e-05	0.000227	CcSEcCtD
Saquinavir—Decreased appetite—Doxorubicin—urinary bladder cancer	4.83e-05	0.000225	CcSEcCtD
Saquinavir—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	4.8e-05	0.000223	CcSEcCtD
Saquinavir—Fatigue—Doxorubicin—urinary bladder cancer	4.79e-05	0.000223	CcSEcCtD
Saquinavir—Urticaria—Epirubicin—urinary bladder cancer	4.77e-05	0.000222	CcSEcCtD
Saquinavir—Constipation—Doxorubicin—urinary bladder cancer	4.75e-05	0.000221	CcSEcCtD
Saquinavir—Pain—Doxorubicin—urinary bladder cancer	4.75e-05	0.000221	CcSEcCtD
Saquinavir—Abdominal pain—Epirubicin—urinary bladder cancer	4.75e-05	0.000221	CcSEcCtD
Saquinavir—Body temperature increased—Epirubicin—urinary bladder cancer	4.75e-05	0.000221	CcSEcCtD
Saquinavir—Hypersensitivity—Methotrexate—urinary bladder cancer	4.73e-05	0.00022	CcSEcCtD
Saquinavir—Asthenia—Methotrexate—urinary bladder cancer	4.6e-05	0.000214	CcSEcCtD
Saquinavir—Feeling abnormal—Doxorubicin—urinary bladder cancer	4.58e-05	0.000213	CcSEcCtD
Saquinavir—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	4.54e-05	0.000211	CcSEcCtD
Saquinavir—Pruritus—Methotrexate—urinary bladder cancer	4.54e-05	0.000211	CcSEcCtD
Saquinavir—Hypersensitivity—Epirubicin—urinary bladder cancer	4.42e-05	0.000206	CcSEcCtD
Saquinavir—Urticaria—Doxorubicin—urinary bladder cancer	4.41e-05	0.000205	CcSEcCtD
Saquinavir—Abdominal pain—Doxorubicin—urinary bladder cancer	4.39e-05	0.000204	CcSEcCtD
Saquinavir—Body temperature increased—Doxorubicin—urinary bladder cancer	4.39e-05	0.000204	CcSEcCtD
Saquinavir—Diarrhoea—Methotrexate—urinary bladder cancer	4.39e-05	0.000204	CcSEcCtD
Saquinavir—Asthenia—Epirubicin—urinary bladder cancer	4.31e-05	0.0002	CcSEcCtD
Saquinavir—Pruritus—Epirubicin—urinary bladder cancer	4.25e-05	0.000198	CcSEcCtD
Saquinavir—Dizziness—Methotrexate—urinary bladder cancer	4.24e-05	0.000197	CcSEcCtD
Saquinavir—Diarrhoea—Epirubicin—urinary bladder cancer	4.11e-05	0.000191	CcSEcCtD
Saquinavir—Hypersensitivity—Doxorubicin—urinary bladder cancer	4.09e-05	0.00019	CcSEcCtD
Saquinavir—Vomiting—Methotrexate—urinary bladder cancer	4.08e-05	0.00019	CcSEcCtD
Saquinavir—Rash—Methotrexate—urinary bladder cancer	4.05e-05	0.000188	CcSEcCtD
Saquinavir—Dermatitis—Methotrexate—urinary bladder cancer	4.04e-05	0.000188	CcSEcCtD
Saquinavir—Headache—Methotrexate—urinary bladder cancer	4.02e-05	0.000187	CcSEcCtD
Saquinavir—Asthenia—Doxorubicin—urinary bladder cancer	3.99e-05	0.000185	CcSEcCtD
Saquinavir—Dizziness—Epirubicin—urinary bladder cancer	3.97e-05	0.000185	CcSEcCtD
Saquinavir—Pruritus—Doxorubicin—urinary bladder cancer	3.93e-05	0.000183	CcSEcCtD
Saquinavir—Vomiting—Epirubicin—urinary bladder cancer	3.82e-05	0.000178	CcSEcCtD
Saquinavir—Nausea—Methotrexate—urinary bladder cancer	3.81e-05	0.000177	CcSEcCtD
Saquinavir—Diarrhoea—Doxorubicin—urinary bladder cancer	3.8e-05	0.000177	CcSEcCtD
Saquinavir—Rash—Epirubicin—urinary bladder cancer	3.79e-05	0.000176	CcSEcCtD
Saquinavir—Dermatitis—Epirubicin—urinary bladder cancer	3.78e-05	0.000176	CcSEcCtD
Saquinavir—Headache—Epirubicin—urinary bladder cancer	3.76e-05	0.000175	CcSEcCtD
Saquinavir—Dizziness—Doxorubicin—urinary bladder cancer	3.67e-05	0.000171	CcSEcCtD
Saquinavir—Nausea—Epirubicin—urinary bladder cancer	3.57e-05	0.000166	CcSEcCtD
Saquinavir—Vomiting—Doxorubicin—urinary bladder cancer	3.53e-05	0.000164	CcSEcCtD
Saquinavir—Rash—Doxorubicin—urinary bladder cancer	3.5e-05	0.000163	CcSEcCtD
Saquinavir—Dermatitis—Doxorubicin—urinary bladder cancer	3.5e-05	0.000163	CcSEcCtD
Saquinavir—Headache—Doxorubicin—urinary bladder cancer	3.48e-05	0.000162	CcSEcCtD
Saquinavir—Nausea—Doxorubicin—urinary bladder cancer	3.3e-05	0.000153	CcSEcCtD
Saquinavir—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	1.43e-05	0.000157	CbGpPWpGaD
Saquinavir—ABCC1—Disease—FGFR3—urinary bladder cancer	1.43e-05	0.000157	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—NAT2—urinary bladder cancer	1.43e-05	0.000157	CbGpPWpGaD
Saquinavir—SLCO1B1—Metabolism—TYMS—urinary bladder cancer	1.43e-05	0.000156	CbGpPWpGaD
Saquinavir—ABCC1—Metabolism—GPX1—urinary bladder cancer	1.42e-05	0.000156	CbGpPWpGaD
Saquinavir—ABCG2—Metabolism—GSTP1—urinary bladder cancer	1.42e-05	0.000156	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.42e-05	0.000155	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—RRM2—urinary bladder cancer	1.42e-05	0.000155	CbGpPWpGaD
Saquinavir—SLCO1B1—Metabolism—GSTM1—urinary bladder cancer	1.41e-05	0.000154	CbGpPWpGaD
Saquinavir—SLCO1B1—Metabolism—NCOR1—urinary bladder cancer	1.41e-05	0.000154	CbGpPWpGaD
Saquinavir—CYP3A7—Metabolism—GSTP1—urinary bladder cancer	1.41e-05	0.000154	CbGpPWpGaD
Saquinavir—ALB—Metabolism—RRM2—urinary bladder cancer	1.41e-05	0.000154	CbGpPWpGaD
Saquinavir—ABCC1—Metabolism—ERCC2—urinary bladder cancer	1.4e-05	0.000153	CbGpPWpGaD
Saquinavir—ALB—Hemostasis—CREBBP—urinary bladder cancer	1.37e-05	0.00015	CbGpPWpGaD
Saquinavir—ALB—Hemostasis—IGF1—urinary bladder cancer	1.35e-05	0.000148	CbGpPWpGaD
Saquinavir—SLCO1B1—Metabolism—GPX1—urinary bladder cancer	1.35e-05	0.000148	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—NAT2—urinary bladder cancer	1.35e-05	0.000148	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—NAT2—urinary bladder cancer	1.34e-05	0.000146	CbGpPWpGaD
Saquinavir—SLCO1B1—Metabolism—ERCC2—urinary bladder cancer	1.33e-05	0.000145	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	1.32e-05	0.000145	CbGpPWpGaD
Saquinavir—ABCG2—Metabolism—TYMS—urinary bladder cancer	1.32e-05	0.000145	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—HPGDS—urinary bladder cancer	1.31e-05	0.000144	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—ENO2—urinary bladder cancer	1.31e-05	0.000144	CbGpPWpGaD
Saquinavir—ABCC1—Metabolism—MTHFR—urinary bladder cancer	1.31e-05	0.000144	CbGpPWpGaD
Saquinavir—SLC22A1—Metabolism—GSTP1—urinary bladder cancer	1.31e-05	0.000144	CbGpPWpGaD
Saquinavir—CYP3A7—Metabolism—TYMS—urinary bladder cancer	1.31e-05	0.000143	CbGpPWpGaD
Saquinavir—ABCG2—Metabolism—GSTM1—urinary bladder cancer	1.31e-05	0.000143	CbGpPWpGaD
Saquinavir—ABCG2—Metabolism—NCOR1—urinary bladder cancer	1.31e-05	0.000143	CbGpPWpGaD
Saquinavir—ALB—Metabolism—ENO2—urinary bladder cancer	1.3e-05	0.000143	CbGpPWpGaD
Saquinavir—ALB—Metabolism—HPGDS—urinary bladder cancer	1.3e-05	0.000143	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.3e-05	0.000143	CbGpPWpGaD
Saquinavir—ALB—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.3e-05	0.000142	CbGpPWpGaD
Saquinavir—CYP3A7—Metabolism—GSTM1—urinary bladder cancer	1.29e-05	0.000142	CbGpPWpGaD
Saquinavir—CYP3A7—Metabolism—NCOR1—urinary bladder cancer	1.29e-05	0.000142	CbGpPWpGaD
Saquinavir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	1.27e-05	0.00014	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—GSTT1—urinary bladder cancer	1.27e-05	0.000139	CbGpPWpGaD
Saquinavir—CYP11A1—Metabolism—PTGS2—urinary bladder cancer	1.27e-05	0.000139	CbGpPWpGaD
Saquinavir—ALB—Metabolism—GSTT1—urinary bladder cancer	1.27e-05	0.000139	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—RRM2—urinary bladder cancer	1.26e-05	0.000138	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.25e-05	0.000137	CbGpPWpGaD
Saquinavir—ABCG2—Metabolism—GPX1—urinary bladder cancer	1.25e-05	0.000137	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	1.25e-05	0.000137	CbGpPWpGaD
Saquinavir—SLCO1B1—Metabolism—MTHFR—urinary bladder cancer	1.25e-05	0.000137	CbGpPWpGaD
Saquinavir—ALB—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.25e-05	0.000136	CbGpPWpGaD
Saquinavir—CYP3A7—Metabolism—GPX1—urinary bladder cancer	1.24e-05	0.000136	CbGpPWpGaD
Saquinavir—ALB—Hemostasis—RHOA—urinary bladder cancer	1.24e-05	0.000136	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—RRM2—urinary bladder cancer	1.23e-05	0.000135	CbGpPWpGaD
Saquinavir—ABCG2—Metabolism—ERCC2—urinary bladder cancer	1.23e-05	0.000134	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—NQO1—urinary bladder cancer	1.22e-05	0.000134	CbGpPWpGaD
Saquinavir—ABCC1—Disease—CREBBP—urinary bladder cancer	1.22e-05	0.000134	CbGpPWpGaD
Saquinavir—SLC22A1—Metabolism—TYMS—urinary bladder cancer	1.22e-05	0.000133	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	1.22e-05	0.000133	CbGpPWpGaD
Saquinavir—CYP3A7—Metabolism—ERCC2—urinary bladder cancer	1.22e-05	0.000133	CbGpPWpGaD
Saquinavir—SLC22A1—Metabolism—NCOR1—urinary bladder cancer	1.2e-05	0.000132	CbGpPWpGaD
Saquinavir—SLC22A1—Metabolism—GSTM1—urinary bladder cancer	1.2e-05	0.000132	CbGpPWpGaD
Saquinavir—ALB—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.18e-05	0.00013	CbGpPWpGaD
Saquinavir—SLCO1A2—Metabolism—PPARG—urinary bladder cancer	1.18e-05	0.000129	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—ENO2—urinary bladder cancer	1.17e-05	0.000128	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	1.17e-05	0.000128	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.16e-05	0.000127	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—RRM2—urinary bladder cancer	1.16e-05	0.000127	CbGpPWpGaD
Saquinavir—ABCG2—Metabolism—MTHFR—urinary bladder cancer	1.15e-05	0.000126	CbGpPWpGaD
Saquinavir—SLC22A1—Metabolism—GPX1—urinary bladder cancer	1.15e-05	0.000126	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—RRM2—urinary bladder cancer	1.15e-05	0.000126	CbGpPWpGaD
Saquinavir—CYP3A7—Metabolism—MTHFR—urinary bladder cancer	1.14e-05	0.000125	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—ENO2—urinary bladder cancer	1.14e-05	0.000125	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—HPGDS—urinary bladder cancer	1.14e-05	0.000125	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	1.14e-05	0.000124	CbGpPWpGaD
Saquinavir—SLCO1A2—Metabolism—CREBBP—urinary bladder cancer	1.14e-05	0.000124	CbGpPWpGaD
Saquinavir—SLC22A1—Metabolism—ERCC2—urinary bladder cancer	1.13e-05	0.000124	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.12e-05	0.000122	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—GSTT1—urinary bladder cancer	1.11e-05	0.000121	CbGpPWpGaD
Saquinavir—CYP11A1—Metabolism—PTEN—urinary bladder cancer	1.11e-05	0.000121	CbGpPWpGaD
Saquinavir—ABCC1—Disease—RHOA—urinary bladder cancer	1.1e-05	0.000121	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—ENO2—urinary bladder cancer	1.08e-05	0.000118	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	1.08e-05	0.000118	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	1.07e-05	0.000117	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—ENO2—urinary bladder cancer	1.07e-05	0.000117	CbGpPWpGaD
Saquinavir—SLC22A1—Metabolism—MTHFR—urinary bladder cancer	1.06e-05	0.000117	CbGpPWpGaD
Saquinavir—ABCC1—Metabolism—PPARG—urinary bladder cancer	1.06e-05	0.000116	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.06e-05	0.000116	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—NQO1—urinary bladder cancer	1.06e-05	0.000116	CbGpPWpGaD
Saquinavir—CYP11A1—Metabolism—EP300—urinary bladder cancer	1.06e-05	0.000116	CbGpPWpGaD
Saquinavir—ALB—Metabolism—NQO1—urinary bladder cancer	1.05e-05	0.000115	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	1.04e-05	0.000114	CbGpPWpGaD
Saquinavir—ALB—Hemostasis—IL2—urinary bladder cancer	1.04e-05	0.000114	CbGpPWpGaD
Saquinavir—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.04e-05	0.000114	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	1.04e-05	0.000113	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.03e-05	0.000112	CbGpPWpGaD
Saquinavir—ABCC1—Metabolism—CREBBP—urinary bladder cancer	1.02e-05	0.000112	CbGpPWpGaD
Saquinavir—ABCC1—Disease—ERBB2—urinary bladder cancer	1.02e-05	0.000112	CbGpPWpGaD
Saquinavir—ALB—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.02e-05	0.000112	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.02e-05	0.000112	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—GSTP1—urinary bladder cancer	1.02e-05	0.000112	CbGpPWpGaD
Saquinavir—SLCO1B1—Metabolism—PPARG—urinary bladder cancer	1.01e-05	0.000111	CbGpPWpGaD
Saquinavir—ABCC1—Disease—PTGS2—urinary bladder cancer	9.99e-06	0.000109	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—TYMP—urinary bladder cancer	9.74e-06	0.000107	CbGpPWpGaD
Saquinavir—SLCO1B1—Metabolism—CREBBP—urinary bladder cancer	9.71e-06	0.000106	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—TYMS—urinary bladder cancer	9.47e-06	0.000104	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—NQO1—urinary bladder cancer	9.44e-06	0.000103	CbGpPWpGaD
Saquinavir—ABCG2—Metabolism—PPARG—urinary bladder cancer	9.36e-06	0.000102	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—GSTM1—urinary bladder cancer	9.36e-06	0.000102	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—NCOR1—urinary bladder cancer	9.36e-06	0.000102	CbGpPWpGaD
Saquinavir—ALB—Hemostasis—EP300—urinary bladder cancer	9.32e-06	0.000102	CbGpPWpGaD
Saquinavir—SLCO1A2—Metabolism—PTGS2—urinary bladder cancer	9.3e-06	0.000102	CbGpPWpGaD
Saquinavir—CYP3A7—Metabolism—PPARG—urinary bladder cancer	9.28e-06	0.000102	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—NQO1—urinary bladder cancer	9.21e-06	0.000101	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	9.16e-06	0.0001	CbGpPWpGaD
Saquinavir—ALB—Hemostasis—SRC—urinary bladder cancer	9.06e-06	9.92e-05	CbGpPWpGaD
Saquinavir—ABCG2—Metabolism—CREBBP—urinary bladder cancer	8.99e-06	9.85e-05	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—GPX1—urinary bladder cancer	8.96e-06	9.81e-05	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	8.95e-06	9.8e-05	CbGpPWpGaD
Saquinavir—CYP3A7—Metabolism—CREBBP—urinary bladder cancer	8.91e-06	9.76e-05	CbGpPWpGaD
Saquinavir—ALB—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	8.9e-06	9.74e-05	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—GSTP1—urinary bladder cancer	8.82e-06	9.66e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—NAT2—urinary bladder cancer	8.81e-06	9.65e-05	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—ERCC2—urinary bladder cancer	8.8e-06	9.63e-05	CbGpPWpGaD
Saquinavir—ALB—Metabolism—GSTP1—urinary bladder cancer	8.77e-06	9.6e-05	CbGpPWpGaD
Saquinavir—ABCC1—Disease—CDKN1A—urinary bladder cancer	8.73e-06	9.56e-05	CbGpPWpGaD
Saquinavir—ABCC1—Disease—PTEN—urinary bladder cancer	8.71e-06	9.54e-05	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—NQO1—urinary bladder cancer	8.68e-06	9.51e-05	CbGpPWpGaD
Saquinavir—SLC22A1—Metabolism—PPARG—urinary bladder cancer	8.63e-06	9.45e-05	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—NQO1—urinary bladder cancer	8.61e-06	9.42e-05	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	8.53e-06	9.34e-05	CbGpPWpGaD
Saquinavir—ALB—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	8.48e-06	9.29e-05	CbGpPWpGaD
Saquinavir—ABCC1—Metabolism—PTGS2—urinary bladder cancer	8.37e-06	9.16e-05	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	8.35e-06	9.14e-05	CbGpPWpGaD
Saquinavir—ABCC1—Disease—EP300—urinary bladder cancer	8.31e-06	9.1e-05	CbGpPWpGaD
Saquinavir—SLC22A1—Metabolism—CREBBP—urinary bladder cancer	8.29e-06	9.08e-05	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—MTHFR—urinary bladder cancer	8.27e-06	9.06e-05	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—TYMS—urinary bladder cancer	8.2e-06	8.98e-05	CbGpPWpGaD
Saquinavir—ALB—Metabolism—TYMS—urinary bladder cancer	8.15e-06	8.93e-05	CbGpPWpGaD
Saquinavir—SLCO1A2—Metabolism—PTEN—urinary bladder cancer	8.11e-06	8.88e-05	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—NCOR1—urinary bladder cancer	8.11e-06	8.88e-05	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—GSTM1—urinary bladder cancer	8.11e-06	8.88e-05	CbGpPWpGaD
Saquinavir—ABCC1—Disease—SRC—urinary bladder cancer	8.08e-06	8.85e-05	CbGpPWpGaD
Saquinavir—ALB—Metabolism—NCOR1—urinary bladder cancer	8.06e-06	8.82e-05	CbGpPWpGaD
Saquinavir—ALB—Metabolism—GSTM1—urinary bladder cancer	8.06e-06	8.82e-05	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	7.99e-06	8.75e-05	CbGpPWpGaD
Saquinavir—SLCO1B1—Metabolism—PTGS2—urinary bladder cancer	7.95e-06	8.71e-05	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	7.87e-06	8.62e-05	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—GPX1—urinary bladder cancer	7.76e-06	8.5e-05	CbGpPWpGaD
Saquinavir—SLCO1A2—Metabolism—EP300—urinary bladder cancer	7.73e-06	8.47e-05	CbGpPWpGaD
Saquinavir—ALB—Metabolism—GPX1—urinary bladder cancer	7.72e-06	8.45e-05	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—GSTP1—urinary bladder cancer	7.68e-06	8.41e-05	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—ERCC2—urinary bladder cancer	7.62e-06	8.34e-05	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	7.62e-06	8.34e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—RRM2—urinary bladder cancer	7.6e-06	8.33e-05	CbGpPWpGaD
Saquinavir—ALB—Metabolism—ERCC2—urinary bladder cancer	7.58e-06	8.3e-05	CbGpPWpGaD
Saquinavir—ALB—Hemostasis—KRAS—urinary bladder cancer	7.5e-06	8.22e-05	CbGpPWpGaD
Saquinavir—ABCG2—Metabolism—PTGS2—urinary bladder cancer	7.36e-06	8.06e-05	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—TYMS—urinary bladder cancer	7.32e-06	8.01e-05	CbGpPWpGaD
Saquinavir—CYP3A7—Metabolism—PTGS2—urinary bladder cancer	7.3e-06	7.99e-05	CbGpPWpGaD
Saquinavir—ABCC1—Metabolism—PTEN—urinary bladder cancer	7.3e-06	7.99e-05	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	7.28e-06	7.97e-05	CbGpPWpGaD
Saquinavir—ABCC1—Disease—MYC—urinary bladder cancer	7.24e-06	7.93e-05	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	7.24e-06	7.93e-05	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	7.23e-06	7.92e-05	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	7.23e-06	7.92e-05	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	7.18e-06	7.86e-05	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—MTHFR—urinary bladder cancer	7.16e-06	7.84e-05	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—TYMS—urinary bladder cancer	7.14e-06	7.82e-05	CbGpPWpGaD
Saquinavir—ALB—Metabolism—MTHFR—urinary bladder cancer	7.12e-06	7.8e-05	CbGpPWpGaD
Saquinavir—ABCC1—Disease—EGFR—urinary bladder cancer	7.08e-06	7.76e-05	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—GSTM1—urinary bladder cancer	7.06e-06	7.73e-05	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—NCOR1—urinary bladder cancer	7.06e-06	7.73e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—ENO2—urinary bladder cancer	7.04e-06	7.71e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	7.04e-06	7.71e-05	CbGpPWpGaD
Saquinavir—ABCC1—Metabolism—EP300—urinary bladder cancer	6.96e-06	7.62e-05	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	6.95e-06	7.6e-05	CbGpPWpGaD
Saquinavir—SLCO1B1—Metabolism—PTEN—urinary bladder cancer	6.93e-06	7.59e-05	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—GPX1—urinary bladder cancer	6.93e-06	7.59e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	6.83e-06	7.48e-05	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	6.8e-06	7.45e-05	CbGpPWpGaD
Saquinavir—SLC22A1—Metabolism—PTGS2—urinary bladder cancer	6.79e-06	7.44e-05	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—GPX1—urinary bladder cancer	6.76e-06	7.4e-05	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—TYMS—urinary bladder cancer	6.73e-06	7.37e-05	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—PPARG—urinary bladder cancer	6.71e-06	7.34e-05	CbGpPWpGaD
Saquinavir—ABCC1—Disease—KRAS—urinary bladder cancer	6.69e-06	7.33e-05	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—TYMS—urinary bladder cancer	6.67e-06	7.31e-05	CbGpPWpGaD
Saquinavir—ALB—Hemostasis—TP53—urinary bladder cancer	6.67e-06	7.3e-05	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	6.65e-06	7.29e-05	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	6.65e-06	7.29e-05	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—ERCC2—urinary bladder cancer	6.64e-06	7.27e-05	CbGpPWpGaD
Saquinavir—SLCO1B1—Metabolism—EP300—urinary bladder cancer	6.61e-06	7.24e-05	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	6.6e-06	7.22e-05	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	6.6e-06	7.22e-05	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—CREBBP—urinary bladder cancer	6.44e-06	7.05e-05	CbGpPWpGaD
Saquinavir—ABCG2—Metabolism—PTEN—urinary bladder cancer	6.42e-06	7.03e-05	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	6.39e-06	7e-05	CbGpPWpGaD
Saquinavir—ALB—Hemostasis—HRAS—urinary bladder cancer	6.38e-06	6.98e-05	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—GPX1—urinary bladder cancer	6.37e-06	6.98e-05	CbGpPWpGaD
Saquinavir—CYP3A7—Metabolism—PTEN—urinary bladder cancer	6.36e-06	6.97e-05	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—GPX1—urinary bladder cancer	6.32e-06	6.92e-05	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	6.26e-06	6.85e-05	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—MTHFR—urinary bladder cancer	6.24e-06	6.83e-05	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	6.2e-06	6.79e-05	CbGpPWpGaD
Saquinavir—ABCG2—Metabolism—EP300—urinary bladder cancer	6.12e-06	6.71e-05	CbGpPWpGaD
Saquinavir—CYP3A7—Metabolism—EP300—urinary bladder cancer	6.07e-06	6.65e-05	CbGpPWpGaD
Saquinavir—SLC22A1—Metabolism—PTEN—urinary bladder cancer	5.92e-06	6.49e-05	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	5.88e-06	6.44e-05	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	5.83e-06	6.38e-05	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—PPARG—urinary bladder cancer	5.81e-06	6.36e-05	CbGpPWpGaD
Saquinavir—ALB—Metabolism—PPARG—urinary bladder cancer	5.78e-06	6.32e-05	CbGpPWpGaD
Saquinavir—ABCC1—Disease—HRAS—urinary bladder cancer	5.69e-06	6.23e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—NQO1—urinary bladder cancer	5.68e-06	6.22e-05	CbGpPWpGaD
Saquinavir—SLC22A1—Metabolism—EP300—urinary bladder cancer	5.65e-06	6.19e-05	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—CREBBP—urinary bladder cancer	5.58e-06	6.11e-05	CbGpPWpGaD
Saquinavir—ALB—Metabolism—CREBBP—urinary bladder cancer	5.55e-06	6.08e-05	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—PTGS2—urinary bladder cancer	5.28e-06	5.78e-05	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—PPARG—urinary bladder cancer	5.18e-06	5.68e-05	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—PPARG—urinary bladder cancer	5.06e-06	5.54e-05	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	4.98e-06	5.45e-05	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—CREBBP—urinary bladder cancer	4.86e-06	5.32e-05	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—PPARG—urinary bladder cancer	4.77e-06	5.22e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	4.73e-06	5.18e-05	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—PPARG—urinary bladder cancer	4.73e-06	5.18e-05	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—PTEN—urinary bladder cancer	4.6e-06	5.04e-05	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	4.58e-06	5.02e-05	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—PTGS2—urinary bladder cancer	4.57e-06	5e-05	CbGpPWpGaD
Saquinavir—ALB—Metabolism—PTGS2—urinary bladder cancer	4.54e-06	4.98e-05	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	4.54e-06	4.97e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—TYMS—urinary bladder cancer	4.4e-06	4.82e-05	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—EP300—urinary bladder cancer	4.39e-06	4.8e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	4.35e-06	4.76e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	4.35e-06	4.76e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—GPX1—urinary bladder cancer	4.17e-06	4.56e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	4.09e-06	4.48e-05	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	4.08e-06	4.47e-05	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—PTEN—urinary bladder cancer	3.99e-06	4.36e-05	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—PTGS2—urinary bladder cancer	3.98e-06	4.36e-05	CbGpPWpGaD
Saquinavir—ALB—Metabolism—PTEN—urinary bladder cancer	3.96e-06	4.34e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	3.84e-06	4.21e-05	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—EP300—urinary bladder cancer	3.8e-06	4.16e-05	CbGpPWpGaD
Saquinavir—ALB—Metabolism—EP300—urinary bladder cancer	3.78e-06	4.14e-05	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	3.75e-06	4.11e-05	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	3.72e-06	4.07e-05	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—PTEN—urinary bladder cancer	3.56e-06	3.89e-05	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—PTEN—urinary bladder cancer	3.47e-06	3.8e-05	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—EP300—urinary bladder cancer	3.39e-06	3.71e-05	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—EP300—urinary bladder cancer	3.31e-06	3.63e-05	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—PTEN—urinary bladder cancer	3.27e-06	3.58e-05	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—PTEN—urinary bladder cancer	3.24e-06	3.55e-05	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—EP300—urinary bladder cancer	3.12e-06	3.42e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—PPARG—urinary bladder cancer	3.12e-06	3.41e-05	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—EP300—urinary bladder cancer	3.09e-06	3.39e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	3e-06	3.28e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	2.45e-06	2.69e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—PTEN—urinary bladder cancer	2.14e-06	2.34e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—EP300—urinary bladder cancer	2.04e-06	2.23e-05	CbGpPWpGaD
